<?xml version="1.0" encoding="UTF-8"?>
<p id="P39">Valacyclovir has also been used to treat acute retinal necrosis and for prevention of CMV disease in kidney transplant recipients.
 <sup>
  <xref ref-type="bibr" rid="R78">78</xref>
 </sup> Although ganciclovir is the backbone for CMV prevention in transplant recipients, the efficacy of valacyclovir prophylaxis for CMV prevention was demonstrated in kidney transplant recipients.
 <sup>
  <xref ref-type="bibr" rid="R78">78</xref>
 </sup> However, valacyclovir has not been proven effective for preventing CMV in heart, liver, lung, pancreas, and small bowel transplant recipients.
</p>
